NGNE · Neurogene Inc. · Proposed Sales
$27.58
+0.91 (+3.41%)
At close · Nov 4
Return incl. dividend (before tax)
Market Cap
$533.70M
Shares
20.01M
Volume · Nov 4
208.56K
Avg daily vol (3M)
291.93K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-03-13 | STUART COBB | Officer | 6,797 | 2026-03-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-27 | Christine Cvijic | Officer | 9,600 | 2026-02-27 | J.P. Morgan Securities LLC |
| 2025-05-14 | STUART COBB | Officer | 6,797 | 2025-05-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-03-07 | MARTIN BABLER | Director | 2,500 | 2024-03-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-03-04 | SEAN SMITH | Officer | 371 | 2024-03-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-02-09 | TODD SIMPSON | Director | 2,500 | 2024-02-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-02-06 | ERIN LAVELLE | Director | 2,500 | 2024-02-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–7 of 7 filings
Key facts
CIK
1404644
CUSIP
64135M105
13F (30d)
23 filings
23 filers
Visit website
Investor relations